PEDIATRICS Vol. 88 No. 6 December 1991, pp. 1286-1287
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TRAYNOR, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TRAYNOR, L. A.

Midazolam-Fentanyl Sedation

LEORA A. TRAYNOR MD1

1 The Allergy and Asthma Clinic, Wadsworth, Ohio 44281

To the Editor.—

Myron Yaster et al are to be congratulated for their candid discussion of the near fatal experience with midazolam-fentanyl described in their article.1

By 1988 at least 88 deaths had been reported to the Food and Drug Administration under similar circumstances; and these represent only the tip of the iceburg because most occurrences are not reported.

Yaster has warned quite correctly that all sedatives become general anesthetics if enough drug is given. Fentanyl, as does any opiate, prolongs and potentiates in unpredictable fashion the effects of midazolam (Versed).